Stock 301108 TONGLING JIEYA BIOLOGIC TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Tongling Jieya Biologic Technology Co., Ltd.

Equities

301108

CNE1000054S9

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-06-06 EDT 		5-day change 1st Jan Change
26.39 CNY +2.09% Intraday chart for Tongling Jieya Biologic Technology Co., Ltd. -1.31% -23.60%
04-25 Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-15 Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tongling Jieya Biologic Technology Co., Ltd. Announces Final Cash Dividend on A Shares for 2023, Payable on 13 June 2024
CI
Tongling Jieya Biologic Technology Co., Ltd. Approves Cash Dividend for the Year 2023
CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tongling Jieya Biologic Technology Co., Ltd. commences an Equity Buyback Plan for CNY 40 million worth of its shares, under the authorization approved on March 13, 2024.
CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Tongling Jieya Biologic Technology Co., Ltd. agreed to acquire 20% stake in Sateri Nonwoven Materials Co., Ltd. from Sateri Fiber Co., Ltd. for CNY 16.5 million.
CI
Tongling Jieya Biologic Technology Co., Ltd. Approves Cash Dividend on A shares for 2022, Payable on 26 May 2023
CI
Tongling Jieya Biologic Technology Co., Ltd. Proposes Final Cash Dividend for 2022
CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Tongling Jieya Biologic to Free Up More than 1 Milion Shares For Trading
MT
Tongling Jieya Biologic Technology Co., Ltd. Approves Final Cash Dividend for the Year 2021
CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Tongling Jieya Biologic Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2021
CI
Tongling Jieya Biologic Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Tongling Jieya Biologic Technology Co., Ltd. has completed an IPO in the amount of CNY 1.162722 billion.
CI
Tongling Jieya Biologic Technology Co., Ltd. has filed an IPO.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 301108 Stock
  4. News Tongling Jieya Biologic Technology Co., Ltd.
  5. Highlights